Kaempferol
Also called kaempferol aglycone, kaempferol glycosides, KMP, quinoa kaempferol.
Best grade D across 4 graded outcomes Other Last checked
The short answer
From 8 sourcesKaempferol is a dietary flavonoid. Nearly all human trials come from one company, Otsuka Pharmaceutical, using 10 mg doses. Small crossover trials found lower oxygen use and heart rate during exercise and more daily steps, but 400-m race times did not improve. A 4-week trial of 50 mg/day found no safety problems.
Every graded outcome on this page
4 rows · line = participantsKey facts
- Exercise oxygen use
- A single 10 mg dose lowered oxygen uptake during submaximal cycling and lengthened time to exhaustion at 100% VO2max vs placebo in 16 trained athletes1
- Race times
- In 13 male athletes running two 400-m races, 10 mg did not change race times but lowered heart and breathing rates and muscle-damage markers in the second run2
- Daily activity and sleep
- Over 2 weeks, 10 mg/day raised daily steps and lowered heart rate vs placebo in 33 office workers, and device-measured sleep quality improved3
- Safety
- 50 mg/day, about five times estimated dietary intake, caused no changes in blood, urine or blood pressure and no adverse events over 4 weeks in 48 adults4
- Absorption from food
- In 8 adults eating endive with 9 mg of kaempferol, blood levels peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose reached the urine in 24 hours7
What it is
Kaempferol is a flavonol found in kale, beans, tea, broccoli and quinoa, sold as a purified supplement.
How it works
ProposedForms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Kaempferol forms compared
2 forms| 2 forms | Aglycone capsules | From foods |
|---|---|---|
| Absorption in people | Not reported in the trial abstracts.413 | In 8 adults eating endive (9 mg kaempferol), plasma kaempferol peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose was excreted in urine within 24 hours, mostly as kaempferol-3-glucuronide.7 |
| GI tolerance | No adverse events at 50 mg/day for 4 weeks.413 | Part of normal diets.6 |
| Studied for | Exercise, activity, sleep, safety | Absorption (pharmacokinetic study); population studies of diet |
- Kaempferol aglycone capsules
- Studied for
- Exercise, activity, sleep, safety
- Kaempferol from foods
- Absorption in people
- In 8 adults eating endive (9 mg kaempferol), plasma kaempferol peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose was excreted in urine within 24 hours, mostly as kaempferol-3-glucuronide.7
- GI tolerance
- Part of normal diets.6
- Studied for
- Absorption (pharmacokinetic study); population studies of diet
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
4 graded outcomes, largest study first4 graded outcomes: 3 improved, 1 mixed. The largest, a 2025 open-label trial of 387 people on Weather-related headache and discomfort, found an improvement.
1Weather-related headache and discomfort
Improved · Grade D · Open-label trial, 387 people, 2025
Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Weather-related headache and discomfort | Improved | 387 | Grade D · Open-label trial, 2025 | Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed |
| Daily steps, heart rate and sleep quality | Improved | 33 | Grade D · Crossover RCT, 2024 | City office workers, 17 men and 16 women (Japan) |
| Oxygen uptake and endurance during cycling | Improved | 16 | Grade D · Crossover RCT, 2025 | Well-trained male university athletes (Japan) |
| Race times and physiological load in repeated 400-m runs | Mixed | 13 | Grade D · Crossover RCT, 2024 | Male university athletes (about 21 years old, Japan) |
Every graded row
4 rowsShowing 4 of 4 outcomes. Human trials only.
DGrade DWeather-related headache and discomfortWeather-related painFewer headaches (uncontrolled)Open-label trial
n 387 · 2025
Improved Headache frequency (Cohen's d 0.61), duration and severity fell from the pre-intervention period; over 80% reported improvement.
- Design
- Open-label trial, n = 387, 2025
- Population
- Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed
- Form
- Kaempferol, no control group
- Dose
- 10 mg/day
- Duration
- 4 weeks
- Source
- Reference 5 · PubMed 40705051 (opens PubMed)
DGrade DDaily steps, heart rate and sleep qualitySleep and activityMore steps, better sleep scoresCrossover RCT
n 33 · 2024
Improved Daily steps and distance rose, heart rate fell at each activity level, and sleep quality measured by a Fitbit improved during kaempferol intake vs placebo.
- Design
- Crossover RCT, n = 33, 2024
- Population
- City office workers, 17 men and 16 women (Japan)
- Form
- Kaempferol vs placebo
- Dose
- 10 mg/day
- Duration
- 2 weeks per period, 7-day washout
- Source
- Reference 3 · PubMed 39155930 (opens PubMed)
DGrade DOxygen uptake and endurance during cyclingEnduranceLower oxygen costCrossover RCT
n 16 · 2025
Improved VO2 and breathing rate were lower at 25%, 50% and 75% VO2max, and exercise time at 100% VO2max was longer (p < 0.05 vs placebo); lactate and respiratory quotient did not rise.
- Design
- Crossover RCT, n = 16, 2025
- Population
- Well-trained male university athletes (Japan)
- Form
- Kaempferol vs placebo
- Dose
- 10 mg once
- Duration
- Single dose
- Source
- Reference 1 · PubMed 40346019 (opens PubMed)
DGrade DRace times and physiological load in repeated 400-m runsSprint performanceNo faster race timesCrossover RCT
n 13 · 2024
Mixed Race times did not differ; heart rate, breathing rate, myoglobin and AST were lower after the second run (p < 0.05).
- Design
- Crossover RCT, n = 13, 2024
- Population
- Male university athletes (about 21 years old, Japan)
- Form
- Kaempferol vs placebo
- Dose
- 10 mg once
- Duration
- Single dose
- Source
- Reference 2 · PubMed 39619966 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
One company's research program
Body signals, not results
Diet links are observational
In US national survey data, each extra 5 mg/day of dietary kaempferol was linked to 7% lower odds of kidney damage in adults with overweight or obesity; this cannot show cause and effect.6
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
When trials measured an effect
3 outcomes| Outcome | Measured at | Basis |
|---|---|---|
| Oxygen use and endurance during cycling | Same day, after a single 10 mg dose | Single-dose crossover trial in 16 trained athletes1 |
| Daily steps and sleep quality (wearable) | Within each 2-week intake period | 10 mg/day crossover in 33 office workers, tracked by a Fitbit through each 2-week period3 |
| Weather-related headache | Week 4 (end of an uncontrolled study) | Questionnaires before and after 4 weeks of 10 mg/day; no placebo group5 |
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Kaempferol and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Kaempferol.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Athletes expecting faster times
- In the only race-performance trial, 10 mg did not change 400-m race times.2
- Drug interactions
- No published human drug-interaction studies were found; LiverTox and LactMed have no kaempferol entry, and the 4-week safety trial did not test medicines.4
- Pregnancy and breastfeeding
- No reliable data on supplements: none of the cited trials included pregnant or breastfeeding women. LactMed's ginkgo entry reports kaempferol from ordinary diets in the breast milk of 17 mothers at 7.8-71.4 nmol/L; supplement doses have not been studied.48
- Higher doses
- Safety has been tested only up to 50 mg/day for 4 weeks in healthy adults.4
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksAglycone dose
Food comparison
The safety trial authors estimate that 50 mg is about five times typical dietary intake, so a 10 mg capsule is roughly a day of normal dietary kaempferol.4
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes kaempferol help sleep?
One 2-week crossover trial in 33 office workers found better sleep quality on a wearable device. It has not been repeated.3
Is kaempferol from food as good as a supplement?
Is kaempferol safe?
A 4-week placebo-controlled trial of 50 mg/day in 48 healthy adults found no changes in blood or urine tests and no adverse events. Longer use is untested.4
Does kaempferol interact with medicines?
No human interaction studies exist, and the 4-week safety trial did not test medicines. The 50 mg safety dose is about five times estimated dietary intake, so the 10 mg trial dose is close to normal dietary amounts.4
What does kaempferol do?
Sources
8 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
8 sources- 1Acute kaempferol ingestion lowers oxygen uptake during submaximal exercise and improves high-intensity exercise capacity in well-trained male athletes.Crossover RCT Physiol Rep, 2025 · PMID 40346019
- 2Kaempferol Reduces Cardiopulmonary Load and Muscular Damage in Repeated 400-m Sprints: A Double-Blind, Randomized, Placebo-Controlled Trial.Crossover RCT Food Sci Nutr, 2024 · PMID 39619966
- 3Effect of kaempferol ingestion on physical activity and sleep quality: a double-blind, placebo-controlled, randomized, crossover trial.Crossover RCT Front Nutr, 2024 · PMID 39155930
- 4A randomized, placebo-controlled trial evaluating the safety of excessive administration of kaempferol aglycone.RCT Food Sci Nutr, 2023 · PMID 37701215
- 5Effects of kaempferol on weather-related pain: an open-label pilot study of subjective headache and other discomforts in pre-intervention and intervention periods in Japan.Open-label trial Int J Biometeorol, 2025 · PMID 40705051
- 6Beneficial Impact of Kaempferol on Kidney Function and Long-Term Prognosis in Overweight or Obese Adults.Observational Food Sci Nutr, 2026 · PMID 41607644
- 7Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans.PK study Eur J Clin Nutr, 2004 · PMID 15164116
- 8GinkgoDatabase LactMed (NCBI Bookshelf), 2025 · ncbi.nlm.nih.gov
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| key facts, forms, who should avoid, FAQ, questions, time to effect, related | Searched PubMed for kaempferol trials and meta-analyses through October 2026: no human trial newer than the 2025 rows exists (an August 2025 correction to the cycling trial fixes a figure and a table but not the reported results), so the evidence table is unchanged. Added a human absorption study (9 mg from endive; peak 0.1 µM at 5.8 h, 1.9% in urine) to the food form, key facts and FAQ, and LactMed's ginkgo entry (kaempferol from ordinary diets measured in breast milk) to a rewritten pregnancy and breastfeeding note. Interaction check: LiverTox and LactMed have no kaempferol entry and PubMed lists no human drug-interaction study; the list stays empty. Added FAQ items on interactions and food versus supplements, time-to-effect rows, page questions and a performance goal-hub link. | Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice. | Writer: Kymata Health EditorialTrigger: new page |
| evidence, safety | Adversarial review: single 33-person crossover (activity and sleep) regraded C to D per the methodology grade rules. | Writer: Kymata Health EditorialTrigger: adversarial review |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.